1 Ferlay J,Soerjomataram I,Dikshit R,et al.Cancer incidence and mortality worldwide:sources,methods and major patterns in GLOBOCAN 2012[J].Int J Cancer,2015,136(5):359-386.
2 Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
3 Fang X,Wei J,He X,et al.Landscape of dietary factors associated with risk of gastric cancer:a systematic review and dose-response meta-analysis of prospective cohort studies[J].Eur J Cancer,2015,51(18):2820-2832.
4 Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
5 周家琛,郑荣寿,庄贵华,等.2000-2015年中国肿瘤登记地区胃癌发病趋势及年龄变化[J].实用肿瘤学杂志,2020,34(1):1-5.
6 Kamangar F.Socio-economic health inequalities:ever-lasting facts or amenable to change?[J].Int J Prev Med,2013,4(6):621-623.
7 Jemal A,Bray F,Center MM,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2):69-90.
8 Karimi P,Islami F,Anandasabapathy S,et al.Gastric cancer:descriptive epidemiology,risk factors,screening,and prevention[J].Cancer Epidemiol Biomarkers Prev,2014,23(5):700-713.
9 Epplein M,Signorello LB,Zheng W,et al.Race,African ancestry,and Helicobacter pylori infection in a low-income United States population[J].Cancer Epidemiol Biomarkers Prev 2011,20(5):826-834.
10 Brown LM,Devesa SS.Epidemiologic trends in esophageal and gastric cancer in the United States[J].Surg Oncol Clin N Am,2002,11(2):235-256.
11 Sanjeevaiah A,Cheedella N,Hester C.Gastric cancer:recent molecular classification advances,racial disparity,and management implications[J].J Oncol Pract,2018,14(4):217-224.
12 张茂祥,孙惠昕,宋冰冰.2008—2012年哈尔滨市道里区恶性肿瘤发病与死亡分析[J].实用肿瘤学杂志,2019,33(3):261-265.
13 Maehara Y,Kakeji Y,Koga T,et al.Therapeutic value of lymph node dissection and the clinical outcome for patients with gastric cancer[J].Surgery,2002,131(1):85-91.
14 杨之洵,郑荣寿,张思维,等.中国胃癌发病趋势及预测[J].中国肿瘤,2019,28(5):321-326.
15 Wang T,Cai H,Sasazuki S,et al.Fruit and vegetable consumption,helicobacter pylori antibodies,and gastric cancer risk:a pooled analysis of prospective studies in china,japan,and korea[J].Int J Cancer,2017,140(3):591-599.
16 Wang XQ,Yan H,Terry PD,et al.Interaction between dietary factors and Helicobacter pylori infection in noncardia gastric cancer:a population-based case-control study in China[J].J Am Coll Nutr,2012,31(5):375-384.
17 Sezikli M,Çetinkaya ZA,Güzelbulut F,et al.Effects of alpha tocopherol and ascorbic acid on Helicobacter pylori colonization and the severity of gastric inflammation[J].Helicobacter,2012,17(2):127-132.
18 Vingeliene S,Chan DS,Aune D,et al.An update of the WCRF/AICR systematic literature review on esophageal and gastric cancers and citrus fruits intake[J].Cancer Causes Control,2016,27(7):837-851.
19 Schwingshackl L,Schwedhelm C,Galbete C,et al.Adherence to mediterranean diet and risk of cancer:an updated systematic review and meta-analysis[J].Nutrients,2017,9(10):1063.
20 Song JH,Kim YS,Heo NJ,et al.High salt intake is associated with atrophic gastritis with intestinal metaplasia[J].Cancer Epidemiol Biomarkers Prev,2017,26(7):1133-1138.
21 Raei N,Behrouz B,Zahri S,et al.Helicobacter pylori infection and dietary Factors act synergistically to promote gastric cancer[J].Asian Pac J Cancer Prev,2016,17(3):917-921.
22 CKhasag O,Boldbaatar G,Tegshee T,et al.The prevalence of Helicobacter pylori infection and other risk factors among mongolian dyspeptic patients who have a high incidence and mortality rate of gastric cancer[J].Gut Pathog,2018,10:14.
23 Thapa S,Fischbach LA,Delongchamp R,et al.Association between Dietary Salt Intake and Progression in the Gastric Precancerous Process[J].Cancers(Basel),2019,11(4):467.
24 Baan R,Straif K,Grosse Y,et al.Carcinogenicity of alcoholic beverages[J].Lancet Oncol,2007,8(4):292-293.
25 Ferro A,Morais S,Rota M,et al.Alcohol intake and gastric cancer:Meta-analyses of published data versus individual participant data pooled analyses[J].Cancer Epidemiol,2018,54:125-132.
26 ANa HK,Lee JY.Molecular basis of alcohol-related gastric and colon cancer[J].Int J Mol Sci,2017,18(6):1116.
27 Maejima R,Iijima K,Kaihovaara P,et al.Effects of ALDH2 genotype,PPI treatment and l-cysteine on carcinogenic acetaldehyde in gastric juice and saliva after intragastric alcohol administration[J].PLoS One,2015,10:e0120397.
28 Tramacere I,Negri E,Pelucchi C,et al.A meta-analysis on alcohol drinking and gastric cancer risk[J].Ann Oncol,2012,23(1):28-36.
29 Bagnardi V,Rota M,Botteri E,et al.Alcohol consumption and site-specific cancer risk:a comprehensive dose-response meta-analysis[J].Br J Cancer,2015,112(3):580-593.
30 Ma K,Baloch Z,He TT,et al.Alcohol consumption and gastric cancer risk:a meta-analysis[J].Med Sci Monit,2017,23:238-246.
31 Kodali RT,Eslick GD.Meta-analysis:does garlic intake reduce risk of gastric cancer[J].Nutr Cancer,2015,67(1):1-11.
32 Turati F,Pelucchi C,Guercio V,et al.Allium vegetable intake and gastric cancer:a case-control study and meta-analysis[J].Mol Nutr Food Res,2015,59(1):171-179.
33 Kim H,Keum N,Giovannucci EL,et al.Garlic intake and gastric cancer risk:Results from two large prospective US cohort studies[J].Int J Cancer,2018,143(5):1047-1053.
34 De Assumpcão PP,Araújo TMT,De Assumpção PB,et al.Suicide journey of H.pylori through gastric carcinogenesis:the role of non-H.pylori microbiome and potential consequences for clinical practice[J].Eur J Clin Microbiol Infect Dis,2019,38(9):1591-1597.
35 Akiba S.Epstein-Barr virus associated gastric carcinoma:epidemiological and clinicopathological features[J].Cancer Sci,2008,99(2):195-201.
36 Huang SC.Prognostic factors in epstein-barr virus-associated stage I-III gastric carcinoma:implications for a unique type of carcinogenesis[J].Oncol Rep,2014,32(2):530-538.
37 Naseem M,Barzi A,Brezden-Masley C,et al.Outlooks on epstein-barr virus associated gastric cancer[J].Cancer Treat Rev,2018,66:15-22.
38 Janarthanan S,Ditah I,Adler DG,et al.Clostridium difficile-associated diarrhea and proton pump inhibitor therapy:a meta-analysis[J].Am J Gastroenterol,2012,107(7):1001-1010.
39 Forgacs I,Loganayagam A.Overprescribing proton pump inhibitors[J].BMJ,2008,336(7634):2-3.
40 Sherwood MW,Melloni C,Jones WS,et al.Individual proton pump inhibitors and outcomes in patients with coronary artery disease on dual antiplatelet therapy:a systematic review[J].J Am Heart Assoc,2015,4(11):e002245.
41 Lundell L,Vieth M,Gibson F,et al.Systematic review:the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology[J].Aliment Pharmacol Ther,2015,42(6):649-663.
42 Cheung KS,Chan EW,Wong AYS,et al.Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori:a population-based study[J].Gut,2018,67(1):28-35.
43 Magee L,Hale L.Longitudinal associations between sleep duration and subsequent weight gain:a systematic review[J].Sleep Med Rev,2012,16(3):231-241.
44 Gu F,Xiao Q,Chu LW,et al.Sleep duration and cancer in the NIH-AARP diet and health study cohort[J].PLoS One,2016,11(9):e0161561.
45 Malik SW,Kaplan J.Sleep deprivation[J].Prim Care,2005,32(2):475-490.
46 Tan P,Yeoh KG.Genetics and molecular pathogenesis of gastric adenocarcinoma[J].Gastroenterology,2015,149(5):1153-1162.
47 Figueiredo C,Machado JC,Pharoah P,et al.Helicobacter pylori and interleukin 1 genotyping:an opportunity to identify high-risk individuals for gastric carcinoma[J].J Natl Cancer Inst,2002,94(22):1680-1687.
48 Persson C,Canedo P,Machado JC,et al.Polymorphisms in inflammatory response genes and their association with gastric cancer:a HuGE systematic review and meta-analyses[J].Am J Epidemiol,2011,173(3):259-270. |